Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LevelsRx vs Mevo Health

LevelsRx
Graded #183

Higher grade

vs+6.3999999999999915
Mevo Health
Graded #326

Lower grade

The verdict

LevelsRx takes it — 66.6/100 to 60.2/100.

LevelsRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LevelsRx is a US direct-to-consumer telehealth offering compounded GLP-1 weight-loss medication, including compounded semaglutide (injectable and an oral liposomal liquid) starting at 150 dollars per month…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLevelsRx +12
68
56
Dose & formulationMevo Health +8
75
83
Clinical oversightLevelsRx +9
76
67
Labs & monitoringEven
52
52
FulfillmentLevelsRx +12
69
57
Contract termsLevelsRx +21
41
20
LevelsRx · left barMevo Health · right bar

The numbers

MetricLevelsRxMevo Health
WeighScore66.6/10060.2/100
GradeCC
Scorecard rank#183#326
Semaglutide$150/mo (starting dose, compounded)$199/mo (all doses, compounded)
Tirzepatide$240/mo (starting dose, compounded)$259/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
LevelsRx

Graded #183 · C

Strengths

  • Both injectable and oral semaglutide plus tirzepatide, with same-day virtual visits
  • Weight-loss money-back warranty if targets are not met
  • 24-7 phone and email support with unlimited online provider visits

Where it loses points

  • Compounding pharmacy is not named publicly
  • States served are not published on the site
  • Prices are 'starting at' figures that may rise with dose
Mevo Health

Graded #326 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard